Help us learn about an investigational formula and it’s health outcomes.
Help us learn about an investigational formula and it’s health outcomes.
MedPharmics is participating in a study on a new hypoallergenic infant formula for newborns up to 65 days old. In this study, they will evaluate the growth, tolerance and compliance of healthy infants fed a commercially available infant formula compared to those fed the new infant formula. Volunteers who qualify for the study may receive study-related care at no cost, investigational formula at no cost and compensation for time and travel.
Fussy baby
Any
You may be compensated for time and travel
Phoenix, AZ / Covington, LA
Active
Infants, up to 65 days
28 days
3 office visits